Niclosamide inhibits vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in injured rat carotid arteries

No abstract is available for this paper.

• Publication year

  2018

• Venue

  British Journal of Pharmacology

• Publication date

  2018-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/bph.14182PMID 29486057PMCID PMC5913402
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Niclosamide inhibits vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in injured rat carotid arteries

  2018cited by this paper
• THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptors

  2017cited by this paper
• Mitochondrial uncoupler triclosan induces vasorelaxation of rat arteries

  2017cited by this paper
• AdipoRon, an adiponectin receptor agonist, attenuates PDGF‐induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia

  2017cited by this paper
• Niclosamide: Beyond an antihelminthic drug

  2017cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

  2017cited by this paper
• ING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathways

  2017cited by this paper
• THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview

  2017cited by this paper
• THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters

  2017cited by this paper
• THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Other ion channels

  2017cited by this paper
• Rubiarbonone C inhibits platelet‐derived growth factor‐induced proliferation and migration of vascular smooth muscle cells through the focal adhesion kinase, MAPK and STAT3 Tyr705 signalling pathways

  2017cited by this paper
• Niclosamide ethanolamine inhibits artery constriction

  2017cited by this paper
• THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes

  2017cited by this paper
• Mitochondrial uncoupler carbonyl cyanide m‐chlorophenylhydrazone induces vasorelaxation without involving KATP channel activation in smooth muscle cells of arteries

  2016cited by this paper
• Anthelmintic drug niclosamide enhances the sensitivity of chronic myeloid leukemia cells to dasatinib through inhibiting Erk/Mnk1/eIF4E pathway.

  2016cited by this paper
• Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats

  2015cited by this paper
• Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP

  2015cited by this paper
• Mitochondrial uncoupling proteins and energy metabolism

  2015cited by this paper
• Experimental design and analysis and their reporting: new guidance for publication in BJP

  2015cited by this paper
• The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor.

  2015cited by this paper
• Dimethyl fumarate induces necroptosis in colon cancer cells through GSH depletion/ROS increase/MAPKs activation pathway

  2015cited by this paper
• Identification of a novel mitochondrial uncoupler that does not depolarize the plasma membrane.

  2014cited by this paper
• Niclosamide ethanolamine improves blood glycemic control and reduces hepatic steatosis in mice

  2014cited by this paper
• Multi-targeted therapy of cancer by niclosamide: A new application for an old drug.

  2014cited by this paper
• Bone Morphogenetic Protein-4 Mediates Cardiac Hypertrophy, Apoptosis, and Fibrosis in Experimentally Pathological Cardiac Hypertrophy

  2013cited by this paper
• AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury.

  2013cited by this paper
• Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler.

  2013cited by this paper
• A novel chemical uncoupler ameliorates obesity and related phenotypes in mice with diet-induced obesity by modulating energy expenditure and food intake

  2013cited by this paper
• Protective effect of nectandrin B, a potent AMPK activator on neointima formation: inhibition of Pin1 expression through AMPK activation

  2013influential reference
• Preventing intimal thickening of vein grafts in vein artery bypass using STAT-3 siRNA

  2012cited by this paper
• Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation

  2012influential reference
• Smooth muscle cell phenotypic switching in atherosclerosis.

  2012cited by this paper
• Wnt4/&bgr;-Catenin Signaling Induces VSMC Proliferation and Is Associated With Intimal Thickening

  2011influential reference
• Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction.

  2011influential reference
• Nonsteroidal Anti-inflammatory Drugs Inhibit Vascular Smooth Muscle Cell Proliferation by Enabling the Ca2+-dependent Inactivation of Calcium Release-activated Calcium/Orai Channels Normally Prevented by Mitochondria*

  2011influential reference
• AMPK 2 Deletion Exacerbates Neointima Formation by Upregulating Skp2 in Vascular Smooth Muscle Cells

  2011cited by this paper
• Mild mitochondrial uncoupling as a therapeutic strategy.

  2011cited by this paper
• Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines

  2010cited by this paper
• Vascular remodeling in transplant vasculopathy.

  2007cited by this paper
• Vascular Remodeling in Transplant Vasculopathy

  2007cited by this paper
• Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation.

  2006cited by this paper
• The effects of the overexpression of recombinant uncoupling protein 2 on proliferation, migration and plasminogen activator inhibitor 1 expression in human vascular smooth muscle cells

  2005cited by this paper
• STAT-3-dependent Cytosolic Phospholipase A2 Expression Is Required for Thrombin-induced Vascular Smooth Muscle Cell Motility*

  2005cited by this paper
• Adenosine Monophosphate-Activated Protein Kinase Suppresses Vascular Smooth Muscle Cell Proliferation Through the Inhibition of Cell Cycle Progression

  2005cited by this paper
• Molecular regulation of vascular smooth muscle cell differentiation in development and disease.

  2004cited by this paper
• AMP-Activated Protein Kinase Inhibits Angiotensin II– Stimulated Vascular Smooth Muscle Cell Proliferation

  2004cited by this paper
• Akt Controls Vascular Smooth Muscle Cell Proliferation In Vitro and In Vivo by Delaying G1/S Exit

  2003cited by this paper
• Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies

  2002cited by this paper
• Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury.

  2000influential reference
• Uncoupling Protein—A Useful Energy Dissepator

  1999cited by this paper
• Histopathology of in-stent restenosis in patients with peripheral artery disease.

  1997cited by this paper
• The mechanisms of action of antiprotozoal and anthelmintic drugs in man.

  1997cited by this paper
• Smooth muscle migration in atherosclerosis and restenosis.

  1997cited by this paper
• The A10 cell line: a model for neonatal, neointimal, or differentiated vascular smooth muscle cells?

  1997influential reference
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper

• Proteomic- and metabolomic-based mechanisms of androgen-mediated right ventricular maladaptive remodeling under pressure overload.

  2025cites this paper
• Nitazoxanide reverses pulmonary vascular remodeling in pulmonary hypertension by targeting the IMPA1-RAGE signaling axis.

  2025cites this paper
• Bif-1 induces vascular remodeling in injured rat carotid artery by engaging β-catenin signaling.

  2025cites this paper
• Targeted delivery of calcium antagonist by side-chain selenium containing polymer for cardiac hypertrophy therapy.

  2025cites this paper
• Combining RNA-seq, molecular docking and experimental verification to explore the mechanism of BAM15 as a potential drug for atherosclerosis

  2025cites this paper
• Role of Trimetazidine in Ameliorating Endothelial Dysfunction: A Review

  2024cites this paper
• Niclosamide modulates phenotypic switch and inflammatory responses in human pulmonary arterial smooth muscle cells

  2024cites this paper
• ROS-Suppression Nanoplatform Combined Activation of STAT3/Bcl-2 Pathway for Preventing Myocardial Infarction in Mice.

  2024cites this paper
• Anthelmintic nitazoxanide protects against experimental pulmonary fibrosis

  2023cites this paper
• Andrographolide inhibits the proliferation and migration of vascular smooth muscle cells by suppressing PI3K/AKT signaling pathway and amino acid metabolic to prevent intimal hyperplasia.

  2023cites this paper
• Overfit deep neural network for predicting drug-target interactions

  2023cites this paper
• Hsa_circ_0001402 alleviates vascular neointimal hyperplasia through a miR-183-5p-dependent regulation of vascular smooth muscle cell proliferation, migration, and autophagy

  2023cites this paper
• Piezo1 channel activation stimulates ATP production through enhancing mitochondrial respiration and glycolysis in vascular endothelial cells

  2023cites this paper
• Delivery of miR-654-5p via SonoVue Microbubble Ultrasound Inhibits Proliferation, Migration, and Invasion of Vascular Smooth Muscle Cells and Arterial Thrombosis and Stenosis through Targeting TCF21

  2022cites this paper
• Tribulus terrestris L. extract ameliorates atherosclerosis by inhibition of vascular smooth muscle cell proliferation in ApoE-/- mice and A7r5 cells via suppression of Akt/MEK/ERK signaling.

  2022cites this paper
• Repurposing nitazoxanide as a novel anti‐atherosclerotic drug based on mitochondrial uncoupling mechanisms

  2022cites this paper
• Niclosamide-loaded nanoparticles (Ncl-NPs) reverse pulmonary fibrosis in vivo and in vitro

  2022influential citation
• Anti-Inflammatory Effects of Thymoquinone in Atherosclerosis: A Mini Review

  2021cites this paper
• Xinmai 'an extract enhances the efficacy of sildenafil in the treatment of pulmonary arterial hypertension via inhibiting MAPK signalling pathway

  2021cites this paper
• Improved Endothelium-Dependent Relaxation of Thoracic Aorta in Niclosamide-Treated Diabetic Rats

  2021cites this paper
• Chemical mitochondrial uncouplers share common inhibitory effect on NLRP3 inflammasome activation through inhibiting NFκB nuclear translocation.

  2021cites this paper
• MicroRNA-1246 regulates proliferation, invasion, and differentiation in human vascular smooth muscle cells by targeting cystic fibrosis transmembrane conductance regulator (CFTR)

  2021cites this paper
• Anthelmintic niclosamide attenuates pressure-overload induced heart failure in mice.

  2021cites this paper
• Niclosamide downregulates LOX-1 expression in mouse vascular smooth muscle cells and changes the composition of atherosclerotic plaques in ApoE−/− mice

  2021cites this paper
• A novel mechanism of Euonymine inhibits in-stent restenosis through enhancing contractile phenotype of VSMCs by targeting AKT1 and p38MAPK

  2021cites this paper
• Anthelmintics nitazoxanide protects against experimental hyperlipidemia and hepatic steatosis in hamsters and mice

  2021cites this paper
• Adipose mesenchymal stem cells and gingival mesenchymal stem cells have a comparable effect in endothelium repair

  2021cites this paper
• Jujuboside B Inhibits Neointimal Hyperplasia and Prevents Vascular Smooth Muscle Cell Dedifferentiation, Proliferation, and Migration via Activation of AMPK/PPAR-γ Signaling

  2021cites this paper
• Niclosamide ethanolamine induces trachea relaxation and inhibits proliferation and migration of trachea smooth muscle cells

  2019cites this paper
• The different response of cardiomyocytes and cardiac fibroblasts to mitochondria inhibition and the underlying role of STAT3

  2019cites this paper
• Activation of cardiac TrkB receptor by its small molecular agonist 7,8‐dihydroxyflavone inhibits doxorubicin‐induced cardiotoxicity via enhancing mitochondrial oxidative phosphorylation

  2019cites this paper
• Thymoquinone suppresses platelet‐derived growth factor‐BB–induced vascular smooth muscle cell proliferation, migration and neointimal formation

  2019cites this paper
• High-throughput transcriptome sequencing reveals the developmental toxicity mechanisms of niclosamide in zebrafish embryo.

  2019cites this paper
• Niclosamide inhibits vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in injured rat carotid arteries

  2018cites this paper